Reata, Bardoxolone and NRF2
in response to
by
...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!
Message: Reata, Bardoxolone and NRF2
Your Vote:
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Reata's Bardoxolone to treat a variety of rare kidney diseases is an activator of Nrf2. You know what else has recently been reported to be an activator of Nrf2 via increased transcription of Nrf2? The pan BET inhibitor JQ1. It would be extremely interesting if apabetalone (bromodomain-2 selective BET inhibitor) also increased the levels of Nrf2.
BearDownAZ
2 Recommendations
Loading...
Loading...
New Message
Please
login
to post a reply